Industry Insights | Pipeline Licensing & Biopharma Trends

Industry Insights

Expert analysis on biopharma industry trends, regulatory updates, and deal practices — providing professional market intelligence to inform your strategic decisions.

Industry Insights2024-12-15

2024 China Biotech Out-Licensing Deal Trends Analysis

In 2024, Chinese biotech out-licensing deals surged to record highs in both volume and value. This article examines the annual deal landscape, leading therapeutic areas, and future outlook.

8 min readRead More

Explore pipeline licensing advisory Explore marketing services